NovaBay Pharmaceuticals Inc (NBY)
0.6855
-0.03
(-4.77%)
USD |
NYAM |
Nov 22, 15:52
NovaBay Pharmaceuticals Revenue (Annual): 14.73M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.73M |
| December 31, 2022 | 14.40M |
| December 31, 2021 | 10.20M |
| December 31, 2020 | 9.934M |
| December 31, 2019 | 6.599M |
| December 31, 2018 | 12.51M |
| December 31, 2017 | 18.23M |
| December 31, 2016 | 11.90M |
| December 31, 2015 | 4.381M |
| Date | Value |
|---|---|
| December 31, 2014 | 1.054M |
| December 31, 2013 | 3.477M |
| December 31, 2012 | 6.947M |
| December 31, 2011 | 11.02M |
| December 31, 2010 | 9.754M |
| December 31, 2009 | 15.68M |
| December 31, 2008 | 6.722M |
| December 31, 2007 | 5.913M |
| December 31, 2006 | 1.533M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
6.599M
Minimum
2019
14.73M
Maximum
2023
11.17M
Average
10.20M
Median
2021
Revenue (Annual) Benchmarks
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
| Nanoviricides Inc | -- |